338 related articles for article (PubMed ID: 7526089)
1. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.
Lamkin T; Brooks J; Annett G; Roberts W; Weinberg K
Leukemia; 1994 Nov; 8(11):1871-8. PubMed ID: 7526089
[TBL] [Abstract][Full Text] [Related]
2. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
Huang S; Law P; Young D; Ho AD
Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
Roy V; Miller JS; Verfaillie CM
Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
[TBL] [Abstract][Full Text] [Related]
4. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
[TBL] [Abstract][Full Text] [Related]
5. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
Marinov J; Koubek K; Starý J
Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
[TBL] [Abstract][Full Text] [Related]
7. Expression of activation antigens CD38 and CD71 is not clinically important in childhood acute lymphoblastic leukemia.
Koehler M; Behm F; Hancock M; Pui CH
Leukemia; 1993 Jan; 7(1):41-5. PubMed ID: 8418378
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells.
Terstappen LW; Safford M; Unterhalt M; Könemann S; Zurlutter K; Piechotka K; Drescher M; Aul C; Büchner T; Hiddemann W
Leukemia; 1992 Oct; 6(10):993-1000. PubMed ID: 1383649
[TBL] [Abstract][Full Text] [Related]
10. Analysis of bone marrow stem cell.
Terstappen LW; Huang S
Blood Cells; 1994; 20(1):45-61; discussion 61-3. PubMed ID: 7527679
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
12. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
[TBL] [Abstract][Full Text] [Related]
13. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells.
Opie TM; Shields LE; Andrews RG
Stem Cells; 1998; 16(5):343-8. PubMed ID: 9766814
[TBL] [Abstract][Full Text] [Related]
14. An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors.
Cardoso AA; Watt SM; Batard P; Li ML; Hatzfeld A; Genevier H; Hatzfeld J
Exp Hematol; 1995 May; 23(5):407-12. PubMed ID: 7536682
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.
Snoeck HW; Lardon F; Lenjou M; Nys G; Van Bockstaele DR; Peetermans ME
Exp Hematol; 1993 Oct; 21(11):1480-6. PubMed ID: 7691636
[TBL] [Abstract][Full Text] [Related]
16. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
18. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: resting stem cells or mystery population?
Randall TD; Weissman IL
Stem Cells; 1998; 16(1):38-48. PubMed ID: 9474746
[TBL] [Abstract][Full Text] [Related]
20. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
Hulkkonen J; Vilpo L; Hurme M; Vilpo J
Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
